Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1995 Apr;48(2):M65–M73. doi: 10.1136/mp.48.2.m65

The study of minimal residual disease in acute lymphoblastic leukaemia

C J C Knechtli 1, N J Goulden 1, K Langlands 1, M N Potter 1
PMCID: PMC407927  PMID: 16695984

Full text

PDF
M65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alt F. W., Baltimore D. Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4118–4122. doi: 10.1073/pnas.79.13.4118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alt F. W., Oltz E. M., Young F., Gorman J., Taccioli G., Chen J. VDJ recombination. Immunol Today. 1992 Aug;13(8):306–314. doi: 10.1016/0167-5699(92)90043-7. [DOI] [PubMed] [Google Scholar]
  3. Aplan P. D., Lombardi D. P., Ginsberg A. M., Cossman J., Bertness V. L., Kirsch I. R. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science. 1990 Dec 7;250(4986):1426–1429. doi: 10.1126/science.2255914. [DOI] [PubMed] [Google Scholar]
  4. Billadeau D., Blackstadt M., Greipp P., Kyle R. A., Oken M. M., Kay N., Van Ness B. Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood. 1991 Dec 1;78(11):3021–3029. [PubMed] [Google Scholar]
  5. Biondi A., Francia di Celle P., Rossi V., Casorati G., Matullo G., Giudici G., Foa R., Migone N. High prevalence of T-cell receptor V delta 2-(D)-D delta 3 or D delta 1/2-D delta 3 rearrangements in B-precursor acute lymphoblastic leukemias. Blood. 1990 May 1;75(9):1834–1840. [PubMed] [Google Scholar]
  6. Biondi A., Yokota S., Hansen-Hagge T. E., Rossi V., Giudici G., Maglia O., Basso G., Tell C., Masera G., Bartram C. R. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia. 1992 Apr;6(4):282–288. [PubMed] [Google Scholar]
  7. Blennerhassett G. T., Furth M. E., Anderson A., Burns J. P., Chaganti R. S., Blick M., Talpaz M., Dev V. G., Chan L. C., Wiedemann L. M. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia. Leukemia. 1988 Oct;2(10):648–657. [PubMed] [Google Scholar]
  8. Bloomfield C. D., Goldman A. I., Alimena G., Berger R., Borgström G. H., Brandt L., Catovsky D., de la Chapelle A., Dewald G. W., Garson O. M. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood. 1986 Feb;67(2):415–420. [PubMed] [Google Scholar]
  9. Boehm T. L., Werle A., Ganser A., Kornhuber B., Drahovsky D. T cell receptor gamma chain variable gene rearrangements in acute lymphoblastic leukemias of T and B lineage. Eur J Immunol. 1987 Nov;17(11):1593–1597. doi: 10.1002/eji.1830171111. [DOI] [PubMed] [Google Scholar]
  10. Borella L., Green A. A., Webster R. G. Immunologic rebound after cessation of long-term chemotherapy in acute leukemia. Blood. 1972 Jul;40(1):42–51. [PubMed] [Google Scholar]
  11. Breit T. M., Mol E. J., Wolvers-Tettero I. L., Ludwig W. D., van Wering E. R., van Dongen J. J. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med. 1993 Apr 1;177(4):965–977. doi: 10.1084/jem.177.4.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Breit T. M., Wolvers-Tettero I. L., Hählen K., van Wering E. R., van Dongen J. J. Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. Leukemia. 1991 Dec;5(12):1076–1086. [PubMed] [Google Scholar]
  13. Brisco M. J., Condon J., Hughes E., Neoh S. H., Sykes P. J., Seshadri R., Toogood I., Waters K., Tauro G., Ekert H. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet. 1994 Jan 22;343(8891):196–200. doi: 10.1016/s0140-6736(94)90988-1. [DOI] [PubMed] [Google Scholar]
  14. Brisco M. J., Condon J., Sykes P. J., Neoh S. H., Morley A. A. Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction. Br J Haematol. 1991 Oct;79(2):211–217. doi: 10.1111/j.1365-2141.1991.tb04524.x. [DOI] [PubMed] [Google Scholar]
  15. Brisco M. J., Tan L. W., Orsborn A. M., Morley A. A. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol. 1990 Jun;75(2):163–167. doi: 10.1111/j.1365-2141.1990.tb02643.x. [DOI] [PubMed] [Google Scholar]
  16. Brown L., Cheng J. T., Chen Q., Siciliano M. J., Crist W., Buchanan G., Baer R. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 1990 Oct;9(10):3343–3351. doi: 10.1002/j.1460-2075.1990.tb07535.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Campana D., Coustan-Smith E., Behm F. G. The definition of remission in acute leukemia with immunologic techniques. Bone Marrow Transplant. 1991 Dec;8(6):429–437. [PubMed] [Google Scholar]
  18. Campana D., Coustan-Smith E., Janossy G. The immunologic detection of minimal residual disease in acute leukemia. Blood. 1990 Jul 1;76(1):163–171. [PubMed] [Google Scholar]
  19. Campana D., Yokota S., Coustan-Smith E., Hansen-Hagge T. E., Janossy G., Bartram C. R. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study. Leukemia. 1990 Sep;4(9):609–614. [PubMed] [Google Scholar]
  20. Cavé H., Guidal C., Rohrlich P., Delfau M. H., Broyart A., Lescoeur B., Rahimy C., Fenneteau O., Monplaisir N., d'Auriol L. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood. 1994 Apr 1;83(7):1892–1902. [PubMed] [Google Scholar]
  21. Chen Q., Cheng J. T., Tasi L. H., Schneider N., Buchanan G., Carroll A., Crist W., Ozanne B., Siciliano M. J., Baer R. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 1990 Feb;9(2):415–424. doi: 10.1002/j.1460-2075.1990.tb08126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Chessells J. M. Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects. Blood Rev. 1992 Dec;6(4):193–203. doi: 10.1016/0268-960x(92)90015-i. [DOI] [PubMed] [Google Scholar]
  23. Cimino G., Moir D. T., Canaani O., Williams K., Crist W. M., Katzav S., Cannizzaro L., Lange B., Nowell P. C., Croce C. M. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res. 1991 Dec 15;51(24):6712–6714. [PubMed] [Google Scholar]
  24. Cline M. J. The molecular basis of leukemia. N Engl J Med. 1994 Feb 3;330(5):328–336. doi: 10.1056/NEJM199402033300507. [DOI] [PubMed] [Google Scholar]
  25. Cole-Sinclair M. F., Foroni L., Hoffbrand A. V. Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia. Baillieres Clin Haematol. 1994 Jun;7(2):183–233. doi: 10.1016/s0950-3536(05)80200-8. [DOI] [PubMed] [Google Scholar]
  26. Crist W. M., Carroll A. J., Shuster J. J., Behm F. G., Whitehead M., Vietti T. J., Look A. T., Mahoney D., Ragab A., Pullen D. J. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood. 1990 Jul 1;76(1):117–122. [PubMed] [Google Scholar]
  27. Davis M. M., Bjorkman P. J. T-cell antigen receptor genes and T-cell recognition. Nature. 1988 Aug 4;334(6181):395–402. doi: 10.1038/334395a0. [DOI] [PubMed] [Google Scholar]
  28. Deane M., Norton J. D. Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification. Br J Haematol. 1990 Mar;74(3):251–256. doi: 10.1111/j.1365-2141.1990.tb02579.x. [DOI] [PubMed] [Google Scholar]
  29. Detection of minimal residual disease in childhood leukemia with the polymerase chain reaction. N Engl J Med. 1991 Mar 14;324(11):772–775. doi: 10.1056/NEJM199103143241113. [DOI] [PubMed] [Google Scholar]
  30. Devaraj P. E., Foroni L., Sekhar M., Butler T., Wright F., Mehta A., Samson D., Prentice H. G., Hoffbrand A. V., Secker-Walker L. M. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia. Leukemia. 1994 Jul;8(7):1131–1138. [PubMed] [Google Scholar]
  31. Djabali M., Selleri L., Parry P., Bower M., Young B. D., Evans G. A. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Genet. 1992 Oct;2(2):113–118. doi: 10.1038/ng1092-113. [DOI] [PubMed] [Google Scholar]
  32. Dyer M. J. T-cell receptor delta/alpha rearrangements in lymphoid neoplasms. Blood. 1989 Aug 15;74(3):1073–1083. [PubMed] [Google Scholar]
  33. Eden O. B., Lilleyman J. S., Richards S., Shaw M. P., Peto J. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol. 1991 Jun;78(2):187–196. doi: 10.1111/j.1365-2141.1991.tb04415.x. [DOI] [PubMed] [Google Scholar]
  34. Felix C. A., Poplack D. G. Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T-cell receptor gene patterns. Leukemia. 1991 Dec;5(12):1015–1025. [PubMed] [Google Scholar]
  35. Felix C. A., Wright J. J., Poplack D. G., Reaman G. H., Cole D., Goldman P., Korsmeyer S. J. T cell receptor alpha-, beta-, and gamma-genes in T cell and pre-B cell acute lymphoblastic leukemia. J Clin Invest. 1987 Aug;80(2):545–556. doi: 10.1172/JCI113103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Gale R. P., Butturini A. Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia. Lancet. 1991 Nov 23;338(8778):1315–1318. doi: 10.1016/0140-6736(91)92604-z. [DOI] [PubMed] [Google Scholar]
  37. Goblet C., Prost E., Whalen R. G. One-step amplification of transcripts in total RNA using the polymerase chain reaction. Nucleic Acids Res. 1989 Mar 11;17(5):2144–2144. doi: 10.1093/nar/17.5.2144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gray J. W., Kuo W. L., Liang J., Pinkel D., van den Engh G., Trask B., Tkachuk D., Waldman F., Westbrook C. Analytical approaches to detection and characterization of disease-linked chromosome aberrations. Bone Marrow Transplant. 1990 Jul;6 (Suppl 1):14–19. [PubMed] [Google Scholar]
  39. Gray J. W., Kuo W. L., Pinkel D. Molecular cytometry applied to detection and characterization of disease-linked chromosome aberrations. Baillieres Clin Haematol. 1991 Jul;4(3):683–693. doi: 10.1016/s0950-3536(09)90007-5. [DOI] [PubMed] [Google Scholar]
  40. Greaves M. F., Mizutani S., Furley A. J., Sutherland D. R., Chan L. C., Ford A. M., Molgaard H. V. Differentiation-linked gene rearrangement and expression in acute lymphoblastic leukaemia. Clin Haematol. 1986 Aug;15(3):621–639. [PubMed] [Google Scholar]
  41. Gu Y., Nakamura T., Alder H., Prasad R., Canaani O., Cimino G., Croce C. M., Canaani E. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell. 1992 Nov 13;71(4):701–708. doi: 10.1016/0092-8674(92)90603-a. [DOI] [PubMed] [Google Scholar]
  42. Hansen-Hagge T. E., Yokota S., Bartram C. R. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences. Blood. 1989 Oct;74(5):1762–1767. [PubMed] [Google Scholar]
  43. Haworth C., Heppleston A. D., Morris Jones P. H., Campbell R. H., Evans D. I., Palmer M. K. Routine bone marrow examination in the management of acute lymphoblastic leukaemia of childhood. J Clin Pathol. 1981 May;34(5):483–485. doi: 10.1136/jcp.34.5.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Heisterkamp N., Jenkins R., Thibodeau S., Testa J. R., Weinberg K., Groffen J. The bcr gene in Philadelphia chromosome positive acute lymphoblastic leukemia. Blood. 1989 Apr;73(5):1307–1311. [PubMed] [Google Scholar]
  45. Hoelzer D., Gale R. P. Acute lymphoblastic leukemia in adults: recent progress, future directions. Semin Hematol. 1987 Jan;24(1):27–39. [PubMed] [Google Scholar]
  46. Hoelzer D. Prognostic factors in acute lymphoblastic leukemia. Leukemia. 1992 Nov;6 (Suppl 4):49–51. [PubMed] [Google Scholar]
  47. Huang C. H., Spruell P., Moulds J. J., Blumenfeld O. O. Molecular basis for the human erythrocyte glycophorin specifying the Miltenberger class I (MiI) phenotype. Blood. 1992 Jul 1;80(1):257–263. [PubMed] [Google Scholar]
  48. Hunger S. P., Galili N., Carroll A. J., Crist W. M., Link M. P., Cleary M. L. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood. 1991 Feb 15;77(4):687–693. [PubMed] [Google Scholar]
  49. Ito Y., Wasserman R., Galili N., Reichard B. A., Shane S., Lange B., Rovera G. Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia. J Clin Oncol. 1993 Mar;11(3):546–553. doi: 10.1200/JCO.1993.11.3.546. [DOI] [PubMed] [Google Scholar]
  50. Jonsson O. G., Kitchens R. L., Baer R. J., Buchanan G. R., Smith R. G. Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia. J Clin Invest. 1991 Jun;87(6):2029–2035. doi: 10.1172/JCI115232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Jonsson O. G., Kitchens R. L., Scott F. C., Smith R. G. Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood. 1990 Nov 15;76(10):2072–2079. [PubMed] [Google Scholar]
  52. Kamps M. P., Murre C., Sun X. H., Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 1990 Feb 23;60(4):547–555. doi: 10.1016/0092-8674(90)90658-2. [DOI] [PubMed] [Google Scholar]
  53. Kantarjian H. M., Deisseroth A., Kurzrock R., Estrov Z., Talpaz M. Chronic myelogenous leukemia: a concise update. Blood. 1993 Aug 1;82(3):691–703. [PubMed] [Google Scholar]
  54. Katz F., Ball L., Gibbons B., Chessells J. The use of DNA probes to monitor minimal residual disease in childhood acute lymphoblastic leukaemia. Br J Haematol. 1989 Oct;73(2):173–180. doi: 10.1111/j.1365-2141.1989.tb00249.x. [DOI] [PubMed] [Google Scholar]
  55. Katz F., Malcolm S., Gibbons B., Tilly R., Lam G., Robertson M. E., Czepulkowski B., Chessells J. Cellular and molecular studies on infant null acute lymphoblastic leukemia. Blood. 1988 May;71(5):1438–1447. [PubMed] [Google Scholar]
  56. Komp D. M., Fischer D. B., Sabio H., McIntosh S. Frequency of bone marrow aspirates to monitor acute lymphoblastic leukemia in childhood. J Pediatr. 1983 Mar;102(3):395–397. doi: 10.1016/s0022-3476(83)80658-1. [DOI] [PubMed] [Google Scholar]
  57. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  58. Loh E. Y., Cwirla S., Serafini A. T., Phillips J. H., Lanier L. L. Human T-cell-receptor delta chain: genomic organization, diversity, and expression in populations of cells. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9714–9718. doi: 10.1073/pnas.85.24.9714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Maurer J., Janssen J. W., Thiel E., van Denderen J., Ludwig W. D., Aydemir U., Heinze B., Fonatsch C., Harbott J., Reiter A. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet. 1991 May 4;337(8749):1055–1058. doi: 10.1016/0140-6736(91)91706-z. [DOI] [PubMed] [Google Scholar]
  60. McCarthy K. P., Sloane J. P., Wiedemann L. M. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol. 1990 May;43(5):429–432. doi: 10.1136/jcp.43.5.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Morgan G. J., Cotter F., Katz F. E., Ridge S. A., Domer P., Korsmeyer S., Wiedemann L. M. Breakpoints at 11q23 in infant leukemias with the t(11;19)(q23;p13) are clustered. Blood. 1992 Nov 1;80(9):2172–2175. [PubMed] [Google Scholar]
  62. Nizet Y., Martiat P., Vaerman J. L., Philippe M., Wildmann C., Staelens J. P., Cornu G., Ferrant A., Michaux J. L., Sokal G. Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. Br J Haematol. 1991 Oct;79(2):205–210. doi: 10.1111/j.1365-2141.1991.tb04523.x. [DOI] [PubMed] [Google Scholar]
  63. Nizet Y., Van Daele S., Lewalle P., Vaerman J. L., Philippe M., Vermylen C., Cornu G., Ferrant A., Michaux J. L., Martiat P. Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction. Blood. 1993 Sep 1;82(5):1618–1625. [PubMed] [Google Scholar]
  64. Nourse J., Mellentin J. D., Galili N., Wilkinson J., Stanbridge E., Smith S. D., Cleary M. L. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell. 1990 Feb 23;60(4):535–545. doi: 10.1016/0092-8674(90)90657-z. [DOI] [PubMed] [Google Scholar]
  65. Ochs J., Mulhern R. Long-term sequelae of therapy for childhood acute lymphoblastic leukaemia. Baillieres Clin Haematol. 1994 Jun;7(2):365–376. doi: 10.1016/s0950-3536(05)80208-2. [DOI] [PubMed] [Google Scholar]
  66. Pelicci P. G., Knowles D. M., 2nd, Dalla Favera R. Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes. J Exp Med. 1985 Sep 1;162(3):1015–1024. doi: 10.1084/jem.162.3.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Potter M. N., Cross N. C., van Dongen J. J., Saglio G., Oakhill A., Bartram C. R., Goldman J. M. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review. Leukemia. 1993 Aug;7(8):1302–1314. [PubMed] [Google Scholar]
  68. Potter M. N., Steward C. G., Oakhill A. The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. Br J Haematol. 1993 Mar;83(3):412–418. doi: 10.1111/j.1365-2141.1993.tb04665.x. [DOI] [PubMed] [Google Scholar]
  69. Pui C. H., Crist W. M., Look A. T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 1990 Oct 15;76(8):1449–1463. [PubMed] [Google Scholar]
  70. Pui C. H., Frankel L. S., Carroll A. J., Raimondi S. C., Shuster J. J., Head D. R., Crist W. M., Land V. J., Pullen D. J., Steuber C. P. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood. 1991 Feb 1;77(3):440–447. [PubMed] [Google Scholar]
  71. Pui C. H., Raimondi S. C., Behm F. G., Ochs J., Furman W. L., Bunin N. J., Ribeiro R. C., Tinsley P. A., Mirro J. Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia. Blood. 1986 Dec;68(6):1306–1310. [PubMed] [Google Scholar]
  72. Raghavachar A., Thiel E., Bartram C. R. Analyses of phenotype and genotype in acute lymphoblastic leukemias at first presentation and in relapse. Blood. 1987 Oct;70(4):1079–1083. [PubMed] [Google Scholar]
  73. Raimondi S. C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993 May 1;81(9):2237–2251. [PubMed] [Google Scholar]
  74. Raimondi S. C., Privitera E., Williams D. L., Look A. T., Behm F., Rivera G. K., Crist W. M., Pui C. H. New recurring chromosomal translocations in childhood acute lymphoblastic leukemia. Blood. 1991 May 1;77(9):2016–2022. [PubMed] [Google Scholar]
  75. Rajagopalan V., Essex D. W., Shapiro S. S., Konkle B. A. Tumor necrosis factor-alpha modulation of glycoprotein Ib alpha expression in human endothelial and erythroleukemia cells. Blood. 1992 Jul 1;80(1):153–161. [PubMed] [Google Scholar]
  76. Rivera G. K., Raimondi S. C., Hancock M. L., Behm F. G., Pui C. H., Abromowitch M., Mirro J., Jr, Ochs J. S., Look A. T., Williams D. L. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet. 1991 Jan 12;337(8733):61–66. doi: 10.1016/0140-6736(91)90733-6. [DOI] [PubMed] [Google Scholar]
  77. Rogers P. C., Bleyer W. A., Coccia P., Lukens J. N., Siegel S., Sather H., Hammond D. Yield of unpredicted bone-marrow relapse diagnosed by routine marrow aspiration in children with acute lymphoblastic leukaemia. A report from the Children's Cancer Study Group. Lancet. 1984 Jun 16;1(8390):1320–1322. doi: 10.1016/s0140-6736(84)91819-1. [DOI] [PubMed] [Google Scholar]
  78. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  79. Sarkar G., Sommer S. S. Shedding light on PCR contamination. Nature. 1990 Jan 4;343(6253):27–27. doi: 10.1038/343027a0. [DOI] [PubMed] [Google Scholar]
  80. Secker-Walker L. M., Chessells J. M., Stewart E. L., Swansbury G. J., Richards S., Lawler S. D. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up. Br J Haematol. 1989 Jul;72(3):336–342. doi: 10.1111/j.1365-2141.1989.tb07713.x. [DOI] [PubMed] [Google Scholar]
  81. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  82. Steward C. G., Goulden N. J., Katz F., Baines D., Martin P. G., Langlands K., Potter M. N., Chessells J. M., Oakhill A. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood. 1994 Mar 1;83(5):1355–1362. [PubMed] [Google Scholar]
  83. Stewart A. K., Schwartz R. S. Immunoglobulin V regions and the B cell. Blood. 1994 Apr 1;83(7):1717–1730. [PubMed] [Google Scholar]
  84. Sykes P. J., Neoh S. H., Brisco M. J., Hughes E., Condon J., Morley A. A. Quantitation of targets for PCR by use of limiting dilution. Biotechniques. 1992 Sep;13(3):444–449. [PubMed] [Google Scholar]
  85. Taylor J. J., Rowe D., Kylefjord H., Chessells J., Katz F., Proctor S. J., Middleton P. G. Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia. Leukemia. 1994 Jan;8(1):60–66. [PubMed] [Google Scholar]
  86. Taylor J. J., Rowe D., Williamson I. K., Christmas S. E., Proctor S. J., Middleton P. G. Detection of T-cell receptor gamma chain V gene rearrangements using the polymerase chain reaction: application to the study of clonal disease cells in acute lymphoblastic leukemia. Blood. 1991 May 1;77(9):1989–1995. [PubMed] [Google Scholar]
  87. Tkachuk D. C., Kohler S., Cleary M. L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell. 1992 Nov 13;71(4):691–700. doi: 10.1016/0092-8674(92)90602-9. [DOI] [PubMed] [Google Scholar]
  88. Trainor K. J., Brisco M. J., Wan J. H., Neoh S., Grist S., Morley A. A. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood. 1991 Jul 1;78(1):192–196. [PubMed] [Google Scholar]
  89. Waldmann T. A., Davis M. M., Bongiovanni K. F., Korsmeyer S. J. Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. N Engl J Med. 1985 Sep 26;313(13):776–783. doi: 10.1056/NEJM198509263131303. [DOI] [PubMed] [Google Scholar]
  90. Walter M. A., Surti U., Hofker M. H., Cox D. W. The physical organization of the human immunoglobulin heavy chain gene complex. EMBO J. 1990 Oct;9(10):3303–3313. doi: 10.1002/j.1460-2075.1990.tb07530.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Wasserman R., Galili N., Ito Y., Silber J. H., Reichard B. A., Shane S., Womer R. B., Lange B., Rovera G. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. J Clin Oncol. 1992 Dec;10(12):1879–1888. doi: 10.1200/JCO.1992.10.12.1879. [DOI] [PubMed] [Google Scholar]
  92. Wasserman R., Yamada M., Ito Y., Finger L. R., Reichard B. A., Shane S., Lange B., Rovera G. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood. 1992 Jan 1;79(1):223–228. [PubMed] [Google Scholar]
  93. Wright J. J., Poplack D. G., Bakhshi A., Reaman G., Cole D., Jensen J. P., Korsmeyer S. J. Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol. 1987 May;5(5):735–741. doi: 10.1200/JCO.1987.5.5.735. [DOI] [PubMed] [Google Scholar]
  94. Yamada M., Hudson S., Tournay O., Bittenbender S., Shane S. S., Lange B., Tsujimoto Y., Caton A. J., Rovera G. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5123–5127. doi: 10.1073/pnas.86.13.5123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Yamada M., Wasserman R., Lange B., Reichard B. A., Womer R. B., Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment. N Engl J Med. 1990 Aug 16;323(7):448–455. doi: 10.1056/NEJM199008163230705. [DOI] [PubMed] [Google Scholar]
  96. Yokota S., Hansen-Hagge T. E., Bartram C. R. T-cell receptor delta gene recombination in common acute lymphoblastic leukemia: preferential usage of V delta 2 and frequent involvement of the J alpha cluster. Blood. 1991 Jan 1;77(1):141–148. [PubMed] [Google Scholar]
  97. Yokota S., Hansen-Hagge T. E., Ludwig W. D., Reiter A., Raghavachar A., Kleihauer E., Bartram C. R. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood. 1991 Jan 15;77(2):331–339. [PubMed] [Google Scholar]
  98. Zehnbauer B. A., Pardoll D. M., Burke P. J., Graham M. L., Vogelstein B. Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemia. Blood. 1986 Mar;67(3):835–838. [PubMed] [Google Scholar]
  99. d'Auriol L., Macintyre E., Galibert F., Sigaux F. In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias. Leukemia. 1989 Feb;3(2):155–158. [PubMed] [Google Scholar]
  100. van Dongen J. J., Breit T. M., Adriaansen H. J., Beishuizen A., Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia. 1992;6 (Suppl 1):47–59. [PubMed] [Google Scholar]
  101. van Dongen J. J., Wolvers-Tettero I. L., Wassenaar F., Borst J., van den Elsen P. Rearrangement and expression of T-cell receptor delta genes in T-cell acute lymphoblastic leukemias. Blood. 1989 Jul;74(1):334–342. [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES